Treatment of alpha chain disease. Results of a prospective study in 21 Tunisian patients by the Tunisian-French intestinal Lymphoma Study Group.
about
The role of infectious agents, antibiotics, and antiviral therapy in the treatment of extranodal marginal zone lymphoma and other low-grade lymphomas.[An immunoproliferative disease of the small intestine revealed by acute intussusception: report of a case].Heavy chain disease.MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis. A mouse model of Helicobacter pylori-induced gastric lymphoma.Extranodal and splenic small B-cell lymphoma.The biology of low grade MALT lymphomaMalignant lymphoma and autoimmune disease.Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue.Five-year results of the treatment of 23 patients with immunoproliferative small intestinal disease: a Turkish experience.Bone marrow involvement in a patient with alpha heavychain disease: response to tetracycline treatmentExtragastric MALT lymphoma.Immunoproliferative Small Intestinal Disease and B-Cell MALT Lymphoma of the Digestive Tract.Transformation of MALT lymphoma to pure plasma cell histology following treatment with the anti-CD20 antibody rituximab.Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma.Extrahepatic cancers and chronic HCV infection.Heavy-Chain Diseases and Myeloma-Associated Fanconi Syndrome: an Update.
P2860
Q30299948-44C7E6E7-D2E6-45F2-975A-9A700D92A10FQ33723353-B08FA884-8BDA-4EB4-B58C-25C2CC307FB7Q34677789-6F2414AD-1F1F-446A-A9F4-88BD6F9A537DQ35796342-958D02D6-F0AB-4D31-85F9-95CA21A21A26Q38071075-3394FFBA-DF17-432D-AD22-B7B78693B6E6Q39648054-5DF3BF04-FCC8-4B5F-ADDD-191AB3CF5592Q40831505-9E8EFDB8-FA54-4ADA-A51A-B63609BB0F49Q41232607-BADB0A8A-9510-41A4-9A27-531462BA7FA2Q41520699-21005CE0-0E10-4D67-8E69-D27C523A4F33Q42202263-306CBFE3-0201-4EBD-B227-833D0409E2CEQ42709031-E2419BD9-ABFC-4389-A0FA-6ABE9511F461Q45781993-C3E179D3-774C-4D10-BCD8-FB6F2ADB4BEDQ46763647-45EC88EF-BB01-4D48-A406-F69E5A2E4420Q47119181-C5219DF7-81E1-4F86-8EC5-90FB498A1FF5Q47552769-5AB42F61-D330-4AA3-9EF1-260F1D8B0E8CQ49774584-03530760-C125-4AEA-A1D9-BEC0AB207A68
P2860
Treatment of alpha chain disease. Results of a prospective study in 21 Tunisian patients by the Tunisian-French intestinal Lymphoma Study Group.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Treatment of alpha chain disea ...... testinal Lymphoma Study Group.
@en
type
label
Treatment of alpha chain disea ...... testinal Lymphoma Study Group.
@en
prefLabel
Treatment of alpha chain disea ...... testinal Lymphoma Study Group.
@en
P2093
P1433
P1476
Treatment of alpha chain disea ...... testinal Lymphoma Study Group.
@en
P2093
Ben Khalifa H
Ben Salah N
Ben-Ayed F
Bouguerra A
Boussene H
Jaafoura H
P304
P356
10.1002/1097-0142(19890401)63:7<1251::AID-CNCR2820630704>3.0.CO;2-H
P407
P577
1989-04-01T00:00:00Z